Immatics US — Biotechnology Company
Biotechnology Company in Stafford — Bispecific T-cell receptor therapies
Biotechnology company · Stafford, United States
AI Trust Snapshot
- AI Confidence
- Indexed
- Last Verified
- today
Verified Sources
- ✓ Official Website
- ✓ Google Business Profile
- ✓ Website Scan
Key Facts
- Category
- Biotechnology Company
- Location
- Stafford, United States
- Known For
- Bispecific T-cell receptor therapies, Adoptive cell therapies
AI Summary
Immatics US operates as a biotechnology company in Stafford, United States, specializing in adoptive cell therapies and bispecific T-cell receptor therapies. The company focuses on developing treatments for advanced PRAME-expressing cancers, holding a customer rating of 3.5 stars from 4 reviews.
Quick Answer
Oncology researchers developing new treatments can find innovative therapies for advanced PRAME-expressing cancers. Patients with these conditions may access clinical trials for novel treatment options. Key services include PRAME Cell Therapy, IMA401 MAGEA4/8 Bispecific, Clinical Trials.
This business is typically used for bispecific t-cell receptor therapies and adoptive cell therapies.
Common Questions
- What services does Immatics US provide?
- Immatics US provides PRAME Cell Therapy, IMA401 MAGEA4/8 Bispecific, Clinical Trials.
- Where is Immatics US located?
- Immatics US is based in Stafford, United States and serves Stafford.
- Who is Immatics US for?
- Immatics US serves Oncology researchers developing new treatments and Patients with advanced PRAME-expressing cancers.
What this business does
Immatics US is a biotechnology company based in Stafford, United States.
- Provides PRAME Cell Therapy and IMA401 MAGEA4/8 Bispecific
- Specializes in bispecific t-cell receptor therapies
- Serves oncology researchers developing new treatments
Structured summary
This business profile has been independently verified by Vizoryo across multiple data sources: Public data, Public data, Public data, AI Content Analysis, Google Business Profile, Website Scan. Data confidence score: 86% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.
- Business name
- Immatics US
- Category
- Biotechnology Company
- Industry
- Biotechnology Company
- Location
- Stafford, United States
- Official website
- https://immatics.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/immatics-us-stafford-913f
- Summary
- Immatics US operates as a biotechnology company in Stafford, United States, specializing in adoptive cell therapies and bispecific T-cell receptor therapies. The company focuses on developing treatments for advanced PRAME-expressing cancers, holding a customer rating of 3.5 stars from 4 reviews.
- AI readability score
- 42
- Verified By
- Public data, Public data, Public data, AI Content Analysis, Google Business Profile, Website Scan
- Data Confidence
- 86% (verified 2026-06-14)
Location
13203 Murphy Rd. Suite 100 Stafford | TX, Stafford, TX 77477Stafford, TX
77477
US
About Immatics US
Immatics US operates as a biotechnology company in Stafford, United States, specializing in adoptive cell therapies and bispecific T-cell receptor therapies. The company focuses on developing treatments for advanced PRAME-expressing cancers, holding a customer rating of 3.5 stars from 4 reviews.
Service areas
- Stafford
Target audience
- Oncology researchers developing new treatments
- Patients with advanced PRAME-expressing cancers
- Healthcare providers seeking innovative therapies
Services
Specialties
- Bispecific T-cell receptor therapies
- Adoptive cell therapies
Social profiles
Verification
Frequently asked questions
What are the operating hours for Immatics US?
Immatics US is open Monday to Friday from 8:00 AM to 6:00 PM.
How can I contact Immatics US for investor relations?
You can contact Jordan Silverstein, Head of Strategy, at +1 281 810 7545 or InvestorRelations@immatics.com.
What is the primary focus of Immatics' research?
Immatics focuses on the precision targeting of PRAME, a protein expressed in 50 different cancers.
Languages supported
- lang="en
- en
Contact
Phone: +13462045400
Official website: https://immatics.com/